Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
GOVT vs XBI: how they differ
GOVT and XBI hold 0% of their weight in the same names, and XBI returned more over the year.
iShares U.S. Treasury Bond ETF and State Street(R) SPDR(R) S&P(R) Biotech ETF.
What they hold in common
By the books each fund has filed, GOVT and XBI hold 0% of their money in the same securities at the same weight.
| Only in GOVT | Only in XBI |
|---|---|
| United States of America 5.31% | Apogee Therapeutics Inc 1.49% |
| United States of America 2.96% | Moderna Inc 1.41% |
| United States of America 2.63% | Twist Bioscience Corp 1.41% |
| United States of America 2.09% | Oruka Therapeutics Inc 1.38% |
| United States of America 1.61% | Kymera Therapeutics Inc 1.36% |
| United States of America 1.57% | Viking Therapeutics Inc 1.31% |
| United States of America 1.53% | Praxis Precision Medicines Inc 1.29% |
| United States of America 1.51% | Erasca Inc 1.27% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
| GOVT iShares U.S. Treasury Bond ETF | XBI State Street(R) SPDR(R) S&P(R) Biotech ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | U.S. Treasury Bond | SPDR S&P Biotech |
| Total return, 1 year | −1.0% | +64.0% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −18.5 pts | +46.5 pts |
| Expense ratio | 0.05% | 0.35% |
| Holdings | 223 | 150 |
GOVT in plain words
GOVT is a bond fund tracking the U.S. Treasury Bond. Over the year to Sep 11, 2026 it returned −1.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.05% a year. It sat 8.4% below its high of Aug 4, 2020 on Sep 11, 2026.
XBI in plain words
XBI is an index equity fund tracking the SPDR S&P Biotech. Over the year to Sep 11, 2026 it returned +64.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. By its holdings filed for Jun 30, 2026, 8% of the fund by weight is stocks the S&P 500 also holds, across 150 positions, with the top ten at 13.3%. It sat 9.6% below its high of Feb 8, 2021 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, GOVT or XBI?
- In the year to Sep 12, 2026, with distributions reinvested, GOVT returned −1.0% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, GOVT or XBI?
- GOVT charges 0.05% a year and XBI charges 0.35%, so GOVT is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, GOVT against XBI, data as of Sep 12, 2026. https://etfiq.com/compare/any/GOVT-XBI Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources